Shanghai Pharma Said To Seek $2.22 Billion From Hong Kong IPO
This article was originally published in PharmAsia News
Executive Summary
Shanghai Pharmaceuticals expects its initial public offering on the Hong Kong market to raise $2.22 billion, according to sources